Clarence Peeples is part of a small club in the HIV community. He is using his experiences to help fight the virus among ...
A multiomic analysis led by the IrsiCaixa AIDS Research Institute has uncovered genetic and immune mechanisms in some ...
Gilead has grown to become a leader in the fight against HIV and has announced efforts to improve access to a new, highly ...
Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
News Medical on MSN2d
Affordability and supply remain critical to the success of long-lasting HIV drugAffordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
Fostemsavir plus optimized background therapy was associated with improvements in immune biomarkers among HTE patients with MDR HIV infection.
Progress has been made in HIV care. However, that doesn’t mean you don’t need a detailed plan for taking care of an ...
Malay Mail on MSN1d
How are bias, religious background and prejudice affecting HIV harm reduction in Malaysia? Doctors relate their experienceSeveral urged for increased education and awareness among healthcare providers to reduce stigma when treating HIV patients in ...
The South African National Aids Council is meant to play a co-ordinating role in the country’s response to HIV, bringing ...
The Ghana AIDS Commission (GAC) says the lack of funding can impact negatively efforts to end AIDS as a public health threat ...
The national HIV prevalence was 16. 3% among adults aged 15 years and older, translating to an estimated 7. 4 million adults ...
GlobalData on MSN2d
Gilead and MSD to advance once-weekly HIV treatment to Phase IIIThe companies have presented positive Phase II data during an oral session at IDWeek 2024, in Los Angeles, US.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback